• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌的分子亚型(NPC)和基于 microRNA 的远处转移预后模型。

Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.

机构信息

Department of Electronic Engineering, City University of Hong Kong, Hong Kong, China.

Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.

出版信息

J Biomed Sci. 2018 Feb 19;25(1):16. doi: 10.1186/s12929-018-0417-5.

DOI:10.1186/s12929-018-0417-5
PMID:29455649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5817810/
Abstract

BACKGROUND

Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic cancer, with diverse molecular characteristics and clinical outcomes. This study aims to dissect the molecular heterogeneity of NPC, followed by the construction of a microRNA (miRNA)-based prognostic model for prediction of distant metastasis.

METHODS

We retrieved two NPC datasets: GSE32960 and GSE70970 as training and validation cohorts, respectively. Consensus clustering was employed for cluster discovery, and support vector machine was used to build a classifier. Finally, Cox regression analysis was applied to constructing a prognostic model for predicting risk of distant metastasis.

RESULTS

Three NPC subtypes (immunogenic, classical and mesenchymal) were identified that are molecularly distinct and clinically relevant, of which mesenchymal subtype (~ 36%) is associated with poor prognosis, characterized by suppressing tumor suppressor miRNAs and the activation of epithelial--mesenchymal transition. Out of the 25 most differentially expressed miRNAs in mesenchymal subtype, miR-142, miR-26a, miR-141 and let-7i have significant prognostic power (P < 0.05).

CONCLUSIONS

We proposed for the first time that NPC can be stratified into three subtypes. Using a panel of 4 miRNAs, we established a prognostic model that can robustly stratify NPC patients into high- and low- risk groups of distant metastasis.

摘要

背景

鼻咽癌(NPC)是一种具有高度侵袭性和转移性的癌症,具有多种分子特征和临床结局。本研究旨在剖析 NPC 的分子异质性,并构建基于 microRNA(miRNA)的预后模型,以预测远处转移。

方法

我们检索了两个 NPC 数据集:GSE32960 和 GSE70970,分别作为训练和验证队列。采用共识聚类进行聚类发现,支持向量机用于构建分类器。最后,应用 Cox 回归分析构建预测远处转移风险的预后模型。

结果

鉴定出三种 NPC 亚型(免疫型、经典型和间质型),它们在分子上是不同的,在临床上也是相关的,其中间质型(约 36%)与预后不良相关,其特征是抑制肿瘤抑制 miRNA 和上皮-间质转化的激活。在间质型中差异表达最显著的 25 个 miRNA 中,miR-142、miR-26a、miR-141 和 let-7i 具有显著的预后预测能力(P<0.05)。

结论

我们首次提出 NPC 可以分为三种亚型。我们使用一组 4 个 miRNA,建立了一个预后模型,可以稳健地将 NPC 患者分为远处转移的高风险和低风险组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/a97fbb1c703b/12929_2018_417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/7992117887d4/12929_2018_417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/9e9ac4522db8/12929_2018_417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/a97fbb1c703b/12929_2018_417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/7992117887d4/12929_2018_417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/9e9ac4522db8/12929_2018_417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/5817810/a97fbb1c703b/12929_2018_417_Fig3_HTML.jpg

相似文献

1
Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.鼻咽癌的分子亚型(NPC)和基于 microRNA 的远处转移预后模型。
J Biomed Sci. 2018 Feb 19;25(1):16. doi: 10.1186/s12929-018-0417-5.
2
Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.鼻咽癌细胞中色素上皮衍生因子的缺乏引发上皮-间质转化和转移。
Cell Death Dis. 2017 Jun 1;8(6):e2838. doi: 10.1038/cddis.2017.114.
3
MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.MicroRNA 谱研究揭示 miR-150 与鼻咽癌转移相关。
Sci Rep. 2017 Sep 20;7(1):12012. doi: 10.1038/s41598-017-10695-2.
4
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.EBV-miR-BART10-3p通过靶向BTRC促进上皮-间质转化并推动鼻咽癌转移。
Oncotarget. 2015 Dec 8;6(39):41766-82. doi: 10.18632/oncotarget.6155.
5
A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.从全基因组血清 miRNA 图谱中鉴定出的一个四 miRNA 特征可预测鼻咽癌患者的生存情况。
Int J Cancer. 2014 Mar 15;134(6):1359-68. doi: 10.1002/ijc.28468. Epub 2013 Sep 30.
6
Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.Let-7a通过靶向鼻咽癌中的HMGA2抑制迁移、侵袭和上皮-间质转化。
J Transl Med. 2015 Mar 31;13:105. doi: 10.1186/s12967-015-0462-8.
7
MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.微小RNA-212通过靶向SOX4抑制鼻咽癌转移。
Oncol Rep. 2017 Jul;38(1):82-88. doi: 10.3892/or.2017.5641. Epub 2017 May 15.
8
microRNA expression profiling of nasopharyngeal carcinoma.鼻咽癌的 microRNA 表达谱分析。
Oncol Rep. 2011 May;25(5):1353-63. doi: 10.3892/or.2011.1204. Epub 2011 Mar 3.
9
hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis.hsa-miR-24 通过调控 c-Myc/上皮-间充质转化轴抑制鼻咽癌转移。
Oncol Rep. 2018 Nov;40(5):2536-2546. doi: 10.3892/or.2018.6690. Epub 2018 Sep 7.
10
Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.通过 miRNA-mRNA 网络挖掘和机器学习鉴定预测鼻咽癌预后和内分泌代谢的标志物。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1174911. doi: 10.3389/fendo.2023.1174911. eCollection 2023.

引用本文的文献

1
Advances in the field of developing biomarkers for re-irradiation: a how-to guide to small, powerful data sets and artificial intelligence.再照射生物标志物开发领域的进展:小型高效数据集与人工智能实用指南
Expert Rev Precis Med Drug Dev. 2024;9(1):3-16. doi: 10.1080/23808993.2024.2325936. Epub 2024 Mar 11.
2
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.鉴定新型分子亚型,以改进鼻咽癌的分类框架。
Br J Cancer. 2024 Apr;130(7):1176-1186. doi: 10.1038/s41416-024-02579-w. Epub 2024 Jan 27.
3
Dual mechanism of Let-7i in tumor progression.

本文引用的文献

1
Increased gene expression noise in human cancers is correlated with low p53 and immune activities as well as late stage cancer.人类癌症中基因表达噪音增加与低p53和免疫活性以及癌症晚期相关。
Oncotarget. 2016 Nov 1;7(44):72011-72020. doi: 10.18632/oncotarget.12457.
2
Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.早期鼻咽癌患者中独特的微小RNA表达
J Cell Mol Med. 2016 Dec;20(12):2259-2268. doi: 10.1111/jcmm.12906. Epub 2016 Aug 4.
3
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.
Let-7i在肿瘤进展中的双重机制。
Front Oncol. 2023 Sep 27;13:1253191. doi: 10.3389/fonc.2023.1253191. eCollection 2023.
4
Editorial: Genomics of immunoregulation and inflammatory responses in the tumor microenvironment.社论:肿瘤微环境中免疫调节与炎症反应的基因组学
Front Genet. 2023 Feb 10;14:1136342. doi: 10.3389/fgene.2023.1136342. eCollection 2023.
5
Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.JNK 和 p38 MAPK 信号通路在鼻咽癌中的功能作用。
Int J Mol Sci. 2022 Jan 20;23(3):1108. doi: 10.3390/ijms23031108.
6
Predicting Radioresistant Biomarkers in Nasopharyngeal Carcinoma Patients Via Protein-Protein Interaction Network Analysis.通过蛋白质-蛋白质相互作用网络分析预测鼻咽癌患者的放射抗性生物标志物
J Lasers Med Sci. 2021 Dec 1;12:e76. doi: 10.34172/jlms.2021.76. eCollection 2021.
7
A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma.一种用于预测鼻咽癌患者生存情况的新型三微小RNA标志物。
J Dent Sci. 2022 Jan;17(1):377-388. doi: 10.1016/j.jds.2021.08.017. Epub 2021 Sep 8.
8
Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma.鉴定五个 miRNA 特征作为鼻咽癌患者新型潜在预后生物标志物。
Hereditas. 2022 Jan 8;159(1):3. doi: 10.1186/s41065-021-00214-9.
9
Clinicopathological analysis and prognostic significance of NF-κB p65 and IKKβ protein and mRNA expression in nasopharyngeal carcinoma.鼻咽癌中 NF-κB p65 和 IKKβ 蛋白及 mRNA 表达的临床病理分析及预后意义。
J Int Med Res. 2022 Jan;50(1):3000605211069195. doi: 10.1177/03000605211069195.
10
Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma.鼻咽癌的发病机制与精准医学进展
MedComm (2020). 2021 Jan 7;2(2):175-206. doi: 10.1002/mco2.32. eCollection 2021 Jun.
Enrichr:一个全面的基因集富集分析网络服务器2016年更新版。
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7. doi: 10.1093/nar/gkw377. Epub 2016 May 3.
4
miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.miR-141通过抑制鼻咽癌中的PTEN/AKT通路参与BRD7介导的细胞增殖和肿瘤形成。
Cell Death Dis. 2016 Mar 24;7(3):e2156. doi: 10.1038/cddis.2016.64.
5
The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment.微小RNA-141在人类癌症中的作用:从诊断到治疗
Cell Physiol Biochem. 2016;38(2):427-48. doi: 10.1159/000438641. Epub 2016 Feb 1.
6
miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.miR-26a通过破坏Lin28B/let-7d轴抑制上皮-间质转化:特发性肺纤维化中微小RNA之间潜在的相互作用。
J Mol Med (Berl). 2016 Jun;94(6):655-65. doi: 10.1007/s00109-016-1381-8. Epub 2016 Jan 20.
7
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.微小RNA-26a通过抑制zeste同源物2增强子来抑制人肝细胞癌中的上皮-间质转化。
J Hematol Oncol. 2016 Jan 6;9:1. doi: 10.1186/s13045-015-0229-y.
8
The consensus molecular subtypes of colorectal cancer.结直肠癌的共识分子亚型
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
9
miRWalk2.0: a comprehensive atlas of microRNA-target interactions.miRWalk2.0:一个全面的微小RNA-靶标相互作用图谱。
Nat Methods. 2015 Aug;12(8):697. doi: 10.1038/nmeth.3485.
10
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Epstein-Barr 病毒编码的 microRNA BART1 通过调节鼻咽癌中 PTEN 依赖性途径诱导肿瘤转移。
Nat Commun. 2015 Jul 2;6:7353. doi: 10.1038/ncomms8353.